3 ms·
The estimate of biological age would be a measure of how damaged you are, and would have a solid statistical relationship with remaining life expectancy. I thi
by joe_the_user 10y ago
The estimate of biological age would be a measure of how damaged you are, and would have a solid statistical relationship with remaining life expectancy.
I think a claim that aging involves only damage is reaching a bit. It seems plausible that each standard phase of human development involve adaptation as well as chromosome damage.
A standard claim is that evolve doesn't care about an organism once it is beyond the age of reproduction. Human beings live considerably longer than other primates and longer past the age of reproduction. One argument is that the extra human lifetime is an adaption to allow an aged human to aid the survival of their offspring. If this is mutation, then one might guess human genes already contain adaptions again usual genetic decay. However this may not be good news since further extending these may be harder than just eliminating the simple aging of simpler organisms.
I know that, just for example, the low metabolisms of the very elderly are seen as a protection against cancer, cancer that would otherwise be more prevalent given accumulative genetic. And this means a failure to lower metabolism over aging time might actually be associated with higher mortality (this may screw up the association of mortality and aging-process measures).
- reasonattlm 10y agoThe root cause is damage. That is the mainstream view in the research community, for all that there is a lot of debate over which damage is actually fundamental and which damage is more important, or how the damage progresses in detail. Then there is secondary and later damage caused by systematic dysregulation resulting from the root cause damage. Then there is adaptation to damage, primary and secondary and later, which is some cases is beneficial and some cases not. E.g. epigenetic changes, stem cell quiescence, cardiovascular remodeling, etc. I'm vaguely optimistic about DNA methylation patterns as the basis for a biomarker precisely because they are not damage, but rather a reaction to that damage. In a way they are an evolved damage assessment, or at least they might be used in that way. We'll see how it pans out in practice over the next five years or so.